Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s Disease

Author:

Domenighetti Cloé1,Sugier Pierre-Emmanuel1,Sreelatha Ashwin Ashok Kumar2,Schulte Claudia34,Grover Sandeep2,Mohamed Océane1,Portugal Berta1,May Patrick5,Bobbili Dheeraj R.56,Radivojkov-Blagojevic Milena7,Lichtner Peter7,Singleton Andrew B.89,Hernandez Dena G.8,Edsall Connor8,Mellick George D.10,Zimprich Alexander11,Pirker Walter12,Rogaeva Ekaterina13,Lang Anthony E.141516,Koks Sulev1718,Taba Pille1920,Lesage Suzanne21,Brice Alexis21,Corvol Jean-Christophe2122,Chartier-Harlin Marie-Christine23,Mutez Eugénie23,Brockmann Kathrin34,Deutschländer Angela B.242526,Hadjigeorgiou Georges M.2728,Dardiotis Efthimos27,Stefanis Leonidas2930,Simitsi Athina Maria29,Valente Enza Maria3132,Petrucci Simona3334,Duga Stefano3536,Straniero Letizia35,Zecchinelli Anna37,Pezzoli Gianni37,Brighina Laura3839,Ferrarese Carlo3839,Annesi Grazia40,Quattrone Andrea41,Gagliardi Monica42,Matsuo Hirotaka43,Kawamura Yusuke43,Hattori Nobutaka44,Nishioka Kenya44,Chung Sun Ju45,Kim Yun Joong46,Kolber Pierre47,van de Warrenburg Bart PC48,Bloem Bastiaan R.48,Aasly Jan49,Toft Mathias50,Pihlstrøm Lasse50,Guedes Leonor Correia5152,Ferreira Joaquim J.5153,Bardien Soraya54,Carr Jonathan55,Tolosa Eduardo5657,Ezquerra Mario58,Pastor Pau5960,Diez-Fairen Monica5960,Wirdefeldt Karin6162,Pedersen Nancy L.62,Ran Caroline63,Belin Andrea C.63,Puschmann Andreas64,Hellberg Clara64,Clarke Carl E.65,Morrison Karen E.66,Tan Manuela67,Krainc Dimitri68,Burbulla Lena F.68,Farrer Matt J.69,Krüger Rejko5477071,Gasser Thomas34,Sharma Manu23,Elbaz Alexis1,

Affiliation:

1. Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Team “Exposome, heredity, cancer and health", CESP, Villejuif, France

2. Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tubingen, Germany

3. Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tubingen, Germany

4. German Center for Neurodegenerative Diseases (DZNE), Tubingen, Germany

5. Translational Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg

6. MeGeno S.A, Esch-sur-Alzette, Luxembourg

7. Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany

8. Molecular Genetics Section, Laboratory of Neurogenetics, NIA, NIH, Bethesda, MD, USA

9. Center For Alzheimer’s and Related Dementias, NIA, NIH, Bethesda, MD, USA

10. Griffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, Queensland, Australia

11. Department of Neurology, Medical University of Vienna, Austria

12. Department of Neurology, Wilhelminenspital, Austria

13. Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada

14. Edmond J. Safra Program in Parkinson’s Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada

15. Division of Neurology, University of Toronto, Toronto, Ontario, Canada

16. Krembil Brain Institute, Toronto, Ontario, Canada

17. Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Murdoch, Australia

18. Perron Institute for Neurological and Translational Science, Nedlands, Western Australia, Australia

19. Department of Neurology and Neurosurgery, University of Tartu, Estonia

20. Neurology Clinic, Tartu University Hospital, Tartu, Estonia

21. Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, Assistance Publique Hôpitaux de Paris, Department of Neurologie, Paris, France

22. Assistance Publique Hôpitaux de Paris, Department of Neurology, CIC Neurosciences, Paris, France

23. Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog- Centre de Recherche Lille Neurosciences & Cognition, Lille, France

24. Department of Neurology, Ludwig Maximilians University of Munich, Germany

25. Department of Neurology, Max Planck Institute of Psychiatry, Munich, Germany

26. Department of Neurology and Department of Clinical Genomics, Mayo Clinic Florida, Jacksonville, FL, USA

27. Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece

28. Department of Neurology, Medical School, University of Cyprus, Nicosia, Cyprus

29. 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

30. Center of Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece

31. Department of Molecular Medicine, University of Pavia, Pavia, Italy

32. Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Mondino Foundation, Pavia, Italy

33. UOC Medical Genetics and Advanced Cell Diagnostics, S. Andrea University Hospital, Rome, Italy

34. Department of Clinical and Molecular Medicine, University of Rome, Rome, Italy

35. Department of Biomedical Sciences - Humanitas University, Milan, Italy

36. Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy

37. Parkinson Institute, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini/CTO, Milano, Italy

38. Department of Neurology, San Gerardo Hospital, Monza, Italy

39. Department of Medicine and Surgery and Milan Center for Neuroscience, University of Milano Bicocca, Milano, Italy

40. Institute for Biomedical Research and Innovation, National Research Council, Cosenza, Italy

41. Institute of Neurology, Magna Graecia University, Catanzaro, Italy

42. Institute of Molecular Bioimaging and Physiology National Research Council, Catanzaro, Italy

43. Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Saitama, Japan

44. Department of Neurology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan

45. Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

46. Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea

47. Neurology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg

48. Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The Netherlands

49. Department of Neurology, St Olav’s Hospital and Norwegian University of Science and Technology, Trondheim, Norway

50. Department of Neurology, Oslo University Hospital, Oslo, Norway

51. Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

52. Department of Neurosciences and Mental Health, Neurology, Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN), Lisbon, Portugal

53. Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

54. Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa

55. Division of Neurology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa

56. Parkinson’s disease & Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain

57. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED: CB06/05/0018-ISCIII) Barcelona, Spain

58. Lab of Parkinson Disease and Other Neurodegenerative Movement Disorders, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Institut de Neurociències, Universitat de Barcelona, Barcelona, Catalonia

59. Fundació per la Recerca Biomèdica i Social Mútua Terrassa, Terrassa, Barcelona, Spain

60. Movement Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, Terrassa, Barcelona, Spain

61. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

62. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

63. Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden

64. Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden

65. University of Birmingham and Sandwell and West Birmingham Hospitals NHS Trust, UK

66. Faculty of Medicine, Health and Life Sciences, Queens University, Belfast, UK

67. Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK

68. Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

69. Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL, USA

70. Parkinson’s Research Clinic, Centre Hospitalier de Luxembourg, Luxembourg

71. Transversal Translational Medicine, Luxembourg Institute of Health (LIH), Strassen, Luxembourg

Abstract

Background: Previous studies showed that lifestyle behaviors (cigarette smoking, alcohol, coffee) are inversely associated with Parkinson’s disease (PD). The prodromal phase of PD raises the possibility that these associations may be explained by reverse causation. Objective: To examine associations of lifestyle behaviors with PD using two-sample Mendelian randomisation (MR) and the potential for survival and incidence-prevalence biases. Methods: We used summary statistics from publicly available studies to estimate the association of genetic polymorphisms with lifestyle behaviors, and from Courage-PD (7,369 cases, 7,018 controls; European ancestry) to estimate the association of these variants with PD. We used the inverse-variance weighted method to compute odds ratios (ORIVW) of PD and 95%confidence intervals (CI). Significance was determined using a Bonferroni-corrected significance threshold (p = 0.017). Results: We found a significant inverse association between smoking initiation and PD (ORIVW per 1-SD increase in the prevalence of ever smoking = 0.74, 95%CI = 0.60–0.93, p = 0.009) without significant directional pleiotropy. Associations in participants ≤67 years old and cases with disease duration ≤7 years were of a similar size. No significant associations were observed for alcohol and coffee drinking. In reverse MR, genetic liability toward PD was not associated with smoking or coffee drinking but was positively associated with alcohol drinking. Conclusion: Our findings are in favor of an inverse association between smoking and PD that is not explained by reverse causation, confounding, and survival or incidence-prevalence biases. Genetic liability toward PD was positively associated with alcohol drinking. Conclusions on the association of alcohol and coffee drinking with PD are hampered by insufficient statistical power.

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3